Clinical Study
Neoadjuvant Chemoradiation in Squamous Cell Carcinoma of the Maxillary Sinus: A 26-Year Experience
Table 1
Patient and tumor characteristics.
| Patients n | 53 | Age (years) | | Mean ± standard deviation | 57.9 ± 11.3 | Median | 58.0 | Minimum/maximum | 18/78 | Gender n (%) | | Male | 41 (77.4%) | Female | 12 (22.6%) | cT-classification n (%) | | T2 | 3 (5.7%) | T3 | 11 (20.8%) | T4a | 34 (64.1%) | T4b | 5 (9.4%) | cN-classification n (%) | | N0 | 28 (52.8%) | N1 | 6 (11.3%) | N2 | 19 (35.8%) | UICC stage grouping n (%) | | II | 2 (3.8%) | III | 10 (18.9%) | IVa | 36 (67.9%) | IVb | 5 (9.4%) | Complete response (CR) n (%) | | No | 42 (79.2%) | Yes | 11 (20.8%) | Orbital infiltration n (%) | | No | 11 (20.8%) | Yes | 42 (79.2%) | Relapse n (%) | | No | 35 (66.0%) | Yes | 18 (34.0%) | Radiotherapy n (%) | | 40 Gy | 18 (34.0%) | 50 Gy | 35 (66.0%) | Chemotherapy n (%) | | Carboplatin | 20 (37.7%) | Cisplatin | 33 (62.3%) |
|
|